C

Cidara Therapeutics

CDTX

12.890
USD
-0.19
(-1.45%)
مغلق
حجم التداول
44
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
91,321,177
أصول ذات صلة
ABBV
4.380
(2.36%)
189.700 USD
AZN
2.040
(2.58%)
81.200 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
LLY
28.47
(3.54%)
832.74 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
الأخبار المقالات

العنوان: Cidara Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak(R) platform targeting oncologic, viral and autoimmune diseases.